Studies of Hypercholesterolemia in the Nonhuman Primate: II. Fatty Streak Conversion to Fibrous Plaque

This report presents the second portion of the morphologic studies on chronic, dietinduced hypercholesterolemia in nonhuman primates (Macaca nemestrina) examined sequentially between 5 and 13 months. A direct relationship was observed between the rate of cholesterol increase, the level and duration of hypercholesterolemia, and the changes in the artery wall that led to the formation of fatty streaks and their conversion to fibrous plaques. A loss of endothelial continuity was first observed in the iliac arteries between 3 and 4 months of atherogenic diet and appears to be a critical step in the conversion of many fatty streaks to fibrous plaques. With breaks in endothelial junctions and exposure of some of the macrophages in a fatty streak, many of the lipid-filled macrophages appeared to detach and enter the circulation. The number of circulating foam cells increased precipitously between 3 and 4 months, the time when increased sites of endothelial dysjunction and macrophage egress were observed. Exposure of subendothelial macrophages also permitted adherence of platelets to these macrophages and to exposed connective tissue. Fibrous plaques were found at similar anatomic sites where endothelial denudation had been observed at earlier time points but were more prevalent in the abdominal aorta and iliac arteries. These changes subsequently occurred at every level of the aortic tree and appeared to progress in a cephalad fashion with increasing rate, level, and duration of hypercholesterolemia.The results of these studies stress the importance of following cholesterol levels of each animal throughout the entire period of the study and of sampling the entire arterial tree at every level with time. This helped us to understand the complicated interrelationships between the various cells in atherogenesis, provided further support for the “Response to Injury Hypothesis of Atherosclerosis” and helped to explain how hypercholesterolemia may be involved in the different stages of atherogenesis in nonhuman primates and possibly in humans.

[1]  R. Ross,et al.  Pathogenesis of Arterial Vascular Disease , 2008, Seminars in thrombosis and hemostasis.

[2]  S. Moore,et al.  Pathogenesis of atherosclerosis. , 1985, Metabolism: clinical and experimental.

[3]  C. E. Becker.  The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. , 1984, JAMA.

[4]  R. Ross,et al.  Studies of Hypercholesterolemia in the Nonhuman Primate: I. Changes that Lead to Fatty Streak Formation , 1984, Arteriosclerosis.

[5]  T. Kita,et al.  Defective lipoprotein receptors and atherosclerosis. Lessons from an animal counterpart of familial hypercholesterolemia. , 1983, The New England journal of medicine.

[6]  A. Chait,et al.  Human arterial wall cells secrete factors that are chemotactic for monocytes. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[7]  D. Steinberg,et al.  Enhanced Macrophage Degradation of Biologically Modified Low Density Lipoprotein , 1983, Arteriosclerosis.

[8]  J. Jauchem,et al.  Mononuclear cell chemoattractant activity from cultured arterial smooth muscle cells. , 1982, Experimental and molecular pathology.

[9]  R. Senior,et al.  Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. , 1982, The Journal of clinical investigation.

[10]  D. Steinberg,et al.  Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. Ross.  George Lyman Duff Memorial Lecture. Atherosclerosis: a problem of the biology of arterial wall cells and their interactions with blood components. , 1981, Arteriosclerosis.

[12]  R. Ross,et al.  Human monocyte-derived growth factor(s) for mesenchymal cells: Activation of secretion by endotoxin and concanavalin A , 1981, Cell.

[13]  Gary R. Grotendorst,et al.  Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[14]  R. Gerrity,et al.  The role of the monocyte in atherogenesis: II. Migration of foam cells from atherosclerotic lesions. , 1981, The American journal of pathology.

[15]  Gerrity Rg.  The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. , 1981 .

[16]  E. Unanue,et al.  Stimulation of nonlymphoid mesenchymal cell proliferation by a macrophage-derived growth factor. , 1981, Journal of immunology.

[17]  C. Nathan,et al.  The macrophage as an effector cell. , 1980, The New England journal of medicine.

[18]  J J Albers,et al.  Platelet-derived growth factor stimulates activity of low density lipoprotein receptors. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[19]  R. Ross,et al.  An endothelial cell-derived growth factor , 1980, The Journal of cell biology.

[20]  G. Majno,et al.  Lymphocytes and monocytes in the aortic intima , 1979 .

[21]  C. Nathan,et al.  Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide , 1979, The Journal of experimental medicine.

[22]  M. Packham.  Methods for Detection of Hypersensitive Platelets , 1978, Thrombosis and Haemostasis.

[23]  J. Hadden,et al.  The induction of macrophage proliferation in vitro by a lymphocyte-produced factor. , 1978, Journal of immunology.

[24]  E. Unanue,et al.  Activated macrophages induce vascular proliferation , 1977, Nature.

[25]  R. Geha,et al.  Clinical Immunology , 1972, The Lancet.

[26]  R. Ross,et al.  The pathogenesis of atherosclerosis (first of two parts). , 1976, The New England journal of medicine.

[27]  J. Hoak,et al.  Platelet aggregates in hypercholesterolemic rhesus monkeys. , 1975, Thrombosis research.

[28]  J. Hoak,et al.  Increased Platelet Aggregates in Patients With Transient Ischemic Attacks , 1975, Stroke.

[29]  A. Keys.  Coronary heart disease--the global picture. , 1975, Atherosclerosis.

[30]  A. Motulsky,et al.  Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. , 1973, The Journal of clinical investigation.

[31]  R. O'Neal,et al.  Poorly differentiated subendothelial cells in swine aortas. , 1970, Experimental and molecular pathology.

[32]  C. Sampson.  The geographic pathology of atherosclerosis. , 1969, Nutrition reviews.

[33]  The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. , 1984, JAMA.

[34]  E. Unanue,et al.  Stimulation of Vascular Cell Growth by Macrophage Products , 1982 .

[35]  R. Gerrity.  The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. , 1981, The American journal of pathology.

[36]  H. Jellinek,et al.  Hematogenic cell infiltration of the aortic intima in normal and hypercholesterolemic swine. Studies on en face endothelium-intima preparations. , 1980, Experimentelle Pathologie.

[37]  H. C. Stary.  Arterial cell injury and cell death in hypercholesterolemia and after reduction of high serum cholesterol levels. , 1977, Progress in biochemical pharmacology.

[38]  M. Brown,et al.  Familial hypercholesterolemia: genetic, biochemical and pathophysiologic considerations. , 1975, Advances in internal medicine.

[39]  R. Steinman,et al.  The Metabolism and Physiology of the Mononuclear Phagocytes , 1974 .